Seer, Inc.
General ticker "SEER" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $128.9M (TTM average)
Seer, Inc. follows the US Stock Market performance with the rate: 25.0%.
Estimated limits based on current volatility of 2.1%: low 1.87$, high 1.95$
Factors to consider:
- Total employees count: 134 (-8.8%) as of 2024
- Top business risk factors: Early stage company with historical losses, Limited operating history, Market acceptance of proteograph, Fluctuating operating results, Pandemic risks
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.59$, 3.91$]
- 2025-12-31 to 2026-12-31 estimated range: [1.46$, 3.60$]
Financial Metrics affecting the SEER estimates:
- Positive: with PPE of -1.7 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -32.64 <= 0.33
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Investing cash flow per share per price, % of 46.62 > -0.66
Short-term SEER quotes
Long-term SEER plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $14.69MM | $15.18MM | $14.17MM |
| Operating Expenses | $112.73MM | $120.12MM | $114.27MM |
| Operating Income | $-98.04MM | $-104.94MM | $-100.10MM |
| Non-Operating Income | $5.08MM | $18.66MM | $13.60MM |
| R&D Expense | $45.80MM | $47.44MM | $50.59MM |
| Income(Loss) | $-92.97MM | $-86.28MM | $-86.50MM |
| Taxes | $0.00MM | $0.00MM | $0.10MM |
| Profit(Loss)* | $-92.97MM | $-86.28MM | $-86.60MM |
| Stockholders Equity | $446.99MM | $396.90MM | $327.57MM |
| Inventory | $4.63MM | $4.49MM | $7.44MM |
| Assets | $487.93MM | $436.27MM | $366.60MM |
| Operating Cash Flow | $-60.78MM | $-59.06MM | $-46.11MM |
| Capital expenditure | $10.27MM | $7.31MM | $3.58MM |
| Investing Cash Flow | $-122.72MM | $37.90MM | $65.86MM |
| Financing Cash Flow | $3.89MM | $0.45MM | $-11.49MM |
| Earnings Per Share** | $-1.49 | $-1.35 | $-1.39 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.